INOVIO PHARMACEUTICALS INC (INO)
US45773H4092 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -135.12M | -279.82M | -303.66M | -167.47M | -120.55M | |||
| Depreciation Amortization | 2.77M | 4.16M | 3.56M | 3.59M | 4.67M | |||
| Income Taxes - Deferred | -32.05K | N/A | 0.00 | 0.00 | 10.00K | |||
| Change In Working Capital | -10.26M | 19.83M | 50.35M | -71.07M | -3.54M | |||
| Interest Paid | 1.07M | 1.07M | 1.08M | 4.62M | 2.72M | |||
| Other non cash items | 18.28M | 39.62M | 34.04M | 56.98M | 21.57M | |||
| OPERATING CASH FLOW | -124.37M | -216.22M | -215.71M | -177.98M | -97.85M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -320.90K | -970.00K | -1.23M | -1.52M | -990.00K | |||
| Other Investing Activity | 87.68M | 110.56M | -174.11M | -57.28M | -8.06M | |||
| INVESTING CASH FLOW | 87.36M | 109.59M | -175.34M | -58.80M | -9.05M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 0.00 | 170.00K | 97.44M | |||
| Stock Issued/Repurchased | 5.00M | 81.84M | 211.50M | 462.73M | 8.31M | |||
| Other Financing Activity | N/A | 0.00 | 0.00 | 2.38M | -350.00K | |||
| FINANCING CASH FLOW | 5.00M | 81.84M | 211.50M | 465.28M | 105.40M | |||
| Exchange Rate Effect | -3.92K | -30.00K | -30.00K | 30.00K | N/A | |||
| CHANGE IN CASH | -32.02M | -24.82M | -179.58M | 228.53M | -1.50M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -124.37M | -216.22M | -215.71M | -177.98M | -97.85M | |||
| Capital Expenditure | -320.90K | -970.00K | -1.23M | -1.52M | -990.00K | |||
| FREE CASH FLOW | -124.69M | -217.19M | -216.94M | -179.50M | -98.84M | |||
All data in USD